Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $216 Million. The most recent transaction as insider was on Jul 29, 2020, when has been sold 1,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M
0% 3M change
1.05% 12M change
Total Value Held $216 Million

Stephane Bancel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 29 2020
SELL
Bona fide gift
-
1,000 Reduced 0.01%
6,683,858 Common Stock
Jul 29 2020
SELL
Open market or private sale
$738,000 $82.0 p/Share
9,000 Reduced 0.13%
6,684,858 Common Stock
Jul 22 2020
SELL
Bona fide gift
-
1,000 Reduced 0.01%
6,693,858 Common Stock
Jul 22 2020
SELL
Open market or private sale
$716,490 $79.61 p/Share
9,000 Reduced 0.13%
6,694,858 Common Stock
Jul 15 2020
SELL
Bona fide gift
-
1,000 Reduced 0.01%
6,703,858 Common Stock
Jul 15 2020
SELL
Open market or private sale
$790,560 $87.84 p/Share
9,000 Reduced 0.13%
6,704,858 Common Stock
Jul 08 2020
SELL
Bona fide gift
-
1,000 Reduced 0.01%
6,713,858 Common Stock
Jul 01 2020
SELL
Bona fide gift
-
1,000 Reduced 0.01%
6,714,858 Common Stock
Jul 01 2020
SELL
Open market or private sale
$566,280 $62.92 p/Share
9,000 Reduced 0.13%
6,715,858 Common Stock
Jun 24 2020
SELL
Bona fide gift
-
1,000 Reduced 0.01%
6,724,858 Common Stock
Jun 24 2020
SELL
Open market or private sale
$569,250 $63.25 p/Share
9,000 Reduced 0.13%
6,725,858 Common Stock
Jun 01 2020
SELL
Open market or private sale
$305,704 $62.67 p/Share
4,878 Reduced 0.07%
6,729,980 Common Stock
May 20 2020
SELL
Open market or private sale
$293,020 $70.0 p/Share
4,186 Reduced 0.06%
6,734,858 Common Stock
May 15 2020
SELL
Bona fide gift
-
1,577 Reduced 0.02%
6,739,044 Common Stock
May 12 2020
BUY
Other acquisition or disposition
-
55,568 Added 0.82%
6,740,621 Common Stock
May 11 2020
SELL
Open market or private sale
$201,108 $59.57 p/Share
3,376 Reduced 0.05%
6,685,053 Common Stock
May 01 2020
SELL
Open market or private sale
$211,796 $48.7 p/Share
4,349 Reduced 0.06%
6,688,429 Common Stock
Apr 20 2020
SELL
Open market or private sale
$192,105 $45.0 p/Share
4,269 Reduced 0.06%
6,692,778 Common Stock
Apr 15 2020
SELL
Bona fide gift
-
2,936 Reduced 0.04%
6,697,047 Common Stock
Apr 13 2020
SELL
Open market or private sale
$100,448 $32.0 p/Share
3,139 Reduced 0.05%
6,699,983 Common Stock
Apr 01 2020
SELL
Open market or private sale
$100,337 $30.05 p/Share
3,339 Reduced 0.05%
6,703,122 Common Stock
Mar 20 2020
SELL
Open market or private sale
$103,033 $29.13 p/Share
3,537 Reduced 0.05%
6,706,461 Common Stock
Mar 16 2020
SELL
Bona fide gift
-
4,676 Reduced 0.07%
6,709,998 Common Stock
Mar 10 2020
SELL
Open market or private sale
$105,848 $25.71 p/Share
4,117 Reduced 0.06%
6,714,674 Common Stock
Mar 02 2020
SELL
Open market or private sale
$104,486 $27.09 p/Share
3,857 Reduced 0.06%
6,718,791 Common Stock
Stephane Bancel

Stephane Bancel

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA